Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα)

https://doi.org/10.1016/j.bmcl.2015.05.093Get rights and content

Abstract

The discovery and optimisation of novel, potent and selective small molecule inhibitors of the α-isoform of type III phosphatidylinositol-4-kinase (PI4Kα) are described. Lead compounds show cellular activity consistent with their PI4Kα potency inhibiting the accumulation of IP1 after PDGF stimulation and reducing cellular PIP, PIP2 and PIP3 levels. Hence, these compounds are useful in vitro tools to delineate the complex biological pathways involved in signalling through PI4Kα.

References and notes (17)

  • L. Delang et al.

    Biochem. Pharmacol.

    (2012)
  • F.H. Vaillancourt et al.

    Virology

    (2009)
  • E.P. Keaney et al.

    Bioorg. Med. Chem. Lett.

    (2014)
  • M.G. Roth

    Physiol. Rev.

    (2004)
  • G. Di Paolo et al.

    Nature

    (2006)
  • T.R. Graham et al.

    Trends Cell Biol.

    (2011)
  • S. Sridhar et al.

    EMBO J.

    (2013)
  • T. Balla et al.

    Trends Cell Biol.

    (2006)
There are more references available in the full text version of this article.

Cited by (0)

View full text